ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "The DAVIO Study: 12 Month Results"
Episode Synopsis
We discuss the 12 month results of the Phase I Davio Trial of an innovative TKI agent for the sustained treatment of neovascular AMD with Dr. Rishi Singh, Professor of Ophthalmology, Cole Eye Insitute, President, Cleveland Cllinic-Martin Hospital, Stuart, Florida.
More episodes of the podcast Retina Synthesis
Stem Cell Therapy for Geographic Atrophy
19/11/2025
8 mg Aflibercept in Diabetic Macular Edema
08/10/2025
Subretinal Gene Therapy for Neovascular AMD
03/10/2025
In God we trust